Hongying Su

735 total citations
21 papers, 358 citations indexed

About

Hongying Su is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Hongying Su has authored 21 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Hongying Su's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), RNA Research and Splicing (4 papers) and Cancer Mechanisms and Therapy (3 papers). Hongying Su is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), RNA Research and Splicing (4 papers) and Cancer Mechanisms and Therapy (3 papers). Hongying Su collaborates with scholars based in China and United States. Hongying Su's co-authors include Han Bao, Xiongfei Huang, Wendong Huang, Jingfeng Liu, Aimin Huang, Xichun Wang, Ningbo Li, Changhui Fu, Jingsong Mao and Dan Long and has published in prestigious journals such as Biomaterials, Biochemical and Biophysical Research Communications and Nanoscale.

In The Last Decade

Hongying Su

20 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongying Su China 11 120 96 92 82 67 21 358
Beini Cen China 11 104 0.9× 75 0.8× 75 0.8× 42 0.5× 43 0.6× 22 301
Zun-Qiang Zhou China 11 108 0.9× 84 0.9× 109 1.2× 146 1.8× 93 1.4× 27 399
Runzhou Zhuang China 12 200 1.7× 55 0.6× 71 0.8× 102 1.2× 61 0.9× 21 393
Xiaoju Shi China 13 126 1.1× 128 1.3× 89 1.0× 77 0.9× 88 1.3× 35 415
Liang Feng China 13 86 0.7× 144 1.5× 59 0.6× 47 0.6× 30 0.4× 16 384
Haiyun Xiong China 11 107 0.9× 78 0.8× 57 0.6× 75 0.9× 27 0.4× 16 361
Lei Dou China 12 123 1.0× 54 0.6× 54 0.6× 60 0.7× 55 0.8× 18 395
Xiaopeng Guo China 11 82 0.7× 45 0.5× 77 0.8× 56 0.7× 23 0.3× 31 337
Shuguang Ju China 12 79 0.7× 79 0.8× 189 2.1× 47 0.6× 99 1.5× 39 368
Man Shu China 11 101 0.8× 145 1.5× 60 0.7× 57 0.7× 47 0.7× 25 418

Countries citing papers authored by Hongying Su

Since Specialization
Citations

This map shows the geographic impact of Hongying Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongying Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongying Su more than expected).

Fields of papers citing papers by Hongying Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongying Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongying Su. The network helps show where Hongying Su may publish in the future.

Co-authorship network of co-authors of Hongying Su

This figure shows the co-authorship network connecting the top 25 collaborators of Hongying Su. A scholar is included among the top collaborators of Hongying Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongying Su. Hongying Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bao, Han, et al.. (2024). Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma. Cancer Control. 31. 2925702869–2925702869. 5 indexed citations
2.
3.
4.
Li, Qianqian, Ningbo Li, Xinrui Wang, et al.. (2020). Nuclear receptor FXR impairs SK‑Hep‑1 cell migration and invasion by inhibiting the Wnt/β‑catenin signaling pathway. Oncology Letters. 20(5). 1–1. 3 indexed citations
5.
Su, Hongying, Tao Xu, Xiongfei Huang, et al.. (2017). Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma. Pathology - Research and Practice. 213(12). 1536–1541. 4 indexed citations
6.
Fu, Changhui, Longfei Tan, Tianlong Liu, et al.. (2017). Imaging-guided synergetic therapy of orthotopic transplantation tumor by superselectively arterial administration of microwave-induced microcapsules. Biomaterials. 133. 144–153. 34 indexed citations
7.
Han, Xiangjun, Fan Zhao, Hongying Su, & Ke Xu. (2017). Outcome of decompression using a transnasal ileus tube in malignant adhesive bowel obstruction: A retrospective study. Molecular and Clinical Oncology. 7(4). 701–705. 8 indexed citations
8.
Mao, Jingsong, Fan Zhao, Meng Niu, et al.. (2017). Therapeutic efficacy of novel microwave-sensitized mPEG-PLGA@ZrO2@(DOX + ILS) drug-loaded microspheres in rabbit VX2 liver tumours. Nanoscale. 9(10). 3429–3439. 31 indexed citations
9.
Bao, Han & Hongying Su. (2017). Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects. BioMed Research International. 2017. 1–8. 29 indexed citations
10.
Zhao, Fan, Hongying Su, Xiangjun Han, Han Bao, & Ji Qi. (2016). Tumor Thermal Ablation Enhancement by Micromaterials. Current Drug Delivery. 14(3). 323–333. 9 indexed citations
11.
Huang, Xiongfei, Xinrui Wang, Xiaoxiao Ma, et al.. (2016). FXR blocks the growth of liver cancer cells through inhibiting mTOR-s6K pathway. Biochemical and Biophysical Research Communications. 474(2). 351–356. 19 indexed citations
12.
Long, Dan, Jingsong Mao, Tianlong Liu, et al.. (2016). Highly stable microwave susceptible agents via encapsulation of Ti-mineral superfine powders in urea-formaldehyde resin microcapsules for tumor hyperthermia therapy. Nanoscale. 8(21). 11044–11051. 23 indexed citations
13.
Chen, Lufeng, et al.. (2014). The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.. PubMed. 61(131). 802–8. 1 indexed citations
14.
Su, Ling‐Yan, Xuelian Li, Li Shen, et al.. (2014). Polymorphisms of TERT and CLPTM1L and the Risk of Hepatocellular Carcinoma in Chinese Males. Asian Pacific Journal of Cancer Prevention. 15(19). 8197–8201. 12 indexed citations
15.
16.
Su, Hongying, Jingfeng Liu, Ningbo Li, et al.. (2012). Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma. American Journal of Physiology-Gastrointestinal and Liver Physiology. 303(11). G1245–G1253. 89 indexed citations
17.
Su, Hongying, Xuelian Li, Xin Xu, et al.. (2010). Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China. Chinese Journal of Cancer Research. 22(4). 260–266. 11 indexed citations
18.
Liu, Linlin, et al.. (2008). [Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].. PubMed. 30(10). 790–2. 4 indexed citations
19.
Xu, Ke, Bo Feng, Hongshan Zhong, et al.. (2003). Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome.. PubMed. 116(4). 609–15. 39 indexed citations
20.
Su, Hongying. (2001). Clinical application study on thrombectomy of iliac-femoral venous thrombosis via transjugular approach. Zhonghua fangshexian yixue zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beini Cen Breakdown of academic impact, for papers by Zun-Qiang Zhou Breakdown of academic impact, for papers by Runzhou Zhuang Breakdown of academic impact, for papers by Xiaoju Shi Breakdown of academic impact, for papers by Liang Feng Breakdown of academic impact, for papers by Haiyun Xiong Breakdown of academic impact, for papers by Lei Dou Breakdown of academic impact, for papers by Xiaopeng Guo Breakdown of academic impact, for papers by Shuguang Ju Breakdown of academic impact, for papers by Man Shu
Rankless by CCL
2026